These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22193519)

  • 1. Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer.
    Pao JB; Yang YP; Huang CN; Huang SP; Hour TC; Chang TY; Lan YH; Lu TL; Lee HZ; Juang SH; Huang CY; Bao BY
    World J Urol; 2013 Apr; 31(2):281-7. PubMed ID: 22193519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer.
    Yang M; Xie W; Mostaghel E; Nakabayashi M; Werner L; Sun T; Pomerantz M; Freedman M; Ross R; Regan M; Sharifi N; Figg WD; Balk S; Brown M; Taplin ME; Oh WK; Lee GS; Kantoff PW
    J Clin Oncol; 2011 Jun; 29(18):2565-73. PubMed ID: 21606417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the BsmI, ApaI, TaqI, Tru9I and FokI Polymorphisms of the Vitamin D Receptor Gene with Nephrolithiasis in the Turkish Population.
    Cakir OO; Yilmaz A; Demir E; Incekara K; Kose MO; Ersoy N
    Urol J; 2016 Mar; 13(1):2509-18. PubMed ID: 26945655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review.
    Chen L; Davey Smith G; Evans DM; Cox A; Lawlor DA; Donovan J; Yuan W; Day IN; Martin RM; Lane A; Rodriguez S; Davis M; Zuccolo L; Collin SM; Hamdy F; Neal D; Lewis SJ
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2874-81. PubMed ID: 19861519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China.
    Bai Y; Yu Y; Yu B; Ge J; Ji J; Lu H; Wei J; Weng Z; Tao Z; Lu J
    BMC Med Genet; 2009 Dec; 10():125. PubMed ID: 19961572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database.
    Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    Eur Urol; 2014 Mar; 65(3):620-7. PubMed ID: 23245686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer.
    Young JWS; Sutradhar R; Rangrej J; Marras C; Fleshner N; Alibhai SMH
    World J Urol; 2017 Sep; 35(9):1417-1423. PubMed ID: 28204918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the androgen transporting gene SLCO2B1 may influence the castration resistance of prostate cancer and the racial differences in response to androgen deprivation.
    Fujimoto N; Kubo T; Inatomi H; Bui HT; Shiota M; Sho T; Matsumoto T
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):336-40. PubMed ID: 23896625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
    Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E
    Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease.
    Gezen-Ak D; Dursun E; Bilgiç B; Hanağasi H; Ertan T; Gürvit H; Emre M; Eker E; Ulutin T; Uysal O; Yilmazer S
    Tohoku J Exp Med; 2012 Nov; 228(3):189-96. PubMed ID: 23076256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
    Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
    Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.
    Misra D; Xie W; Regan MM; Ross RW; Lee GS; Germain D; Kantoff PW; Oh WK
    BJU Int; 2011 Oct; 108(7):1086-91. PubMed ID: 21410629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor gene polymorphisms in children with kidney stone disease.
    Subaşı B; Gökçe İ; Delil K; Alpay H
    Turk J Pediatr; 2017; 59(4):404-409. PubMed ID: 29624220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy.
    Bao BY; Pao JB; Huang CN; Pu YS; Chang TY; Lan YH; Lu TL; Lee HZ; Juang SH; Chen LM; Hsieh CJ; Huang SP
    Clin Cancer Res; 2011 Feb; 17(4):928-36. PubMed ID: 21149617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple prognostic model involving prostate-specific antigen, alkaline phosphatase and albumin for predicting the time required to progress to castration-resistant prostate cancer in patients who received androgen deprivation therapy.
    Lv W; Shang H; Pei X; Chen Y; Xie H; He D; Wang X; Li L
    Int Urol Nephrol; 2017 Jan; 49(1):61-67. PubMed ID: 27837416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
    Cicek MS; Liu X; Schumacher FR; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2549-52. PubMed ID: 17164384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.
    Bosco C; Bosnyak Z; Malmberg A; Adolfsson J; Keating NL; Van Hemelrijck M
    Eur Urol; 2015 Sep; 68(3):386-96. PubMed ID: 25484142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Receptor Polymorphisms Associated with Autism Spectrum Disorder.
    Guerini FR; Bolognesi E; Chiappedi M; Mensi MM; Fumagalli O; Rogantini C; Zanzottera M; Ghezzo A; Zanette M; Agliardi C; Costa AS; Sotgiu S; Carta A; Al Daghri N; Clerici M
    Autism Res; 2020 May; 13(5):680-690. PubMed ID: 32083397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect.
    Ross RW; Xie W; Regan MM; Pomerantz M; Nakabayashi M; Daskivich TJ; Sartor O; Taplin ME; Kantoff PW; Oh WK
    Cancer; 2008 Mar; 112(6):1247-53. PubMed ID: 18293426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.